Guardian Pharmacy Services, Inc.
NYSE:GRDNMedical - Distribution
+$0.17 today
- Market cap
- $3.09B
- Beta
- 0.08
- P/E (TTM)
- 52.0
- EPS (TTM)
- $0.84
Volume 0.45M
Average 0.48M
GRDN Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
Guardian Pharmacy Services, Inc.NYSE: GRDN
Operating Expenses · Q2 FY2026 · quarter ended Jun 2026
Operating expenses growth accelerates
Q2 FY2026 operating expenses of $59.4M rose 6.9% year over year, ahead of the -30.3% change in trailing-twelve-month operating expenses. Sequentially, it rose 1.3% from the prior quarter. Over 3 fiscal years it compounded at +13.0% a year.
Context
- Operating expenses amounted to 13.3% of revenue in FY2025, down 11.7 pp from a year earlier.
- Operating expenses increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +6.9% holds above the trailing-twelve-month pace of -30.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
USD · from the income statement
- Latest · FY2025
- 193.13M USD
- Year-over-year change
- -37.2%
- 4-year CAGR
- +10.2%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 193.13M | -37.2% |
| FY2024 | 2024-12-31 | 307.29M | +83.6% |
| FY2023 | 2023-12-31 | 167.36M | +25.0% |
| FY2022 | 2022-12-31 | 133.88M | +2.1% |
| FY2021 | 2021-12-31 | 131.12M | — |
Operating Expenses vs competitors
How GRDN compares with its peers on the latest reported figures
- GRDN's LTM Jun 2026 operating expenses of $224.83M is the 7th highest of the 11 companies compared; the peer median is $304.53M.
- Its year-over-year change of -30.3% is the lowest of 11, against a peer median of +21.8%.
- Operating expenses amounts to 15.4% of revenue for GRDN, versus a peer median of 83.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $2.17B | +48.1% | +26.2% | 81.8% | |
| LTM Sep 2026 | $516.85M | -3.0% | -0.5% | 83.6% | |
| LTM Sep 2026 | $380.26M | +16.2% | +7.4% | 82.8% | |
| LTM Sep 2026 | $351.84M | -23.0% | +9.6% | 22.2% | |
| LTM Mar 2026 | $311.83M | +23.4% | +36.6% | 96.8% | |
| LTM Jun 2026 | $297.23M | +30.0% | +30.7% | 174.9% | |
GRDNGuardian Pharmacy Services, Inc. | LTM Jun 2026 | $224.83M | -30.3% | +13.0% | 15.4% |
| LTM Sep 2026 | $217.59M | +20.2% | +38.2% | — | |
| LTM Sep 2026 | $207.61M | -30.1% | -6.5% | 10.6% | |
| LTM Mar 2026 | $168.69M | +127.4% | +30.3% | 780.5% | |
| LTM Jun 2026 | $154.86M | +108.9% | +25.9% | 128.8% | |
| Peer median (excluding GRDN) | $304.53M | +21.8% | +26.0% | 83.6% | |
Competitors are the stored peer set for GRDN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 792.07M | 908.91M | 1.05B | 1.23B | 1.45B |
| Cost of Revenue | 630.81M | 723.04M | 837.88M | 984.04M | 1.17B |
| Gross Profit | 161.27M | 185.87M | 208.31M | 244.37M | 282.04M |
| Gross Margin | 20.4% | 20.4% | 19.9% | 19.9% | 19.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 131.12M | 133.88M | 167.36M | 307.29M | 193.13M |
| Operating Expenses | 131.12M | 133.88M | 167.36M | 307.29M | 193.13M |
| Depreciation & Amortization | 16.53M | 16.56M | 18.23M | 19.77M | 22.34M |
| EBITDA | 46.49M | 68.15M | 58.81M | (43.43M) | 96.42M |
| EBITDA Margin | 5.9% | 7.5% | 5.6% | -3.5% | 6.7% |
| Operating Income | 30.15M | 51.99M | 40.95M | (62.92M) | 88.91M |
| Operating Margin | 3.8% | 5.7% | 3.9% | -5.1% | 6.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.64M | 1.93M | 2.86M | 3.28M | 665K |
| Other Income / Expenses | (1.82M) | (2.33M) | (3.23M) | (3.56M) | (15.49M) |
| Income Before Tax | 28.33M | 49.66M | 37.72M | (66.48M) | 73.42M |
| Pre-Tax Margin | 3.6% | 5.5% | 3.6% | -5.4% | 5.1% |
| Income Tax Expense | 0 | 0 | 0 | 4.56M | 24.47M |
| Net Income | 16.31M | 35.42M | 23.9M | (87.29M) | 49.22M |
| Net Margin | 2.1% | 3.9% | 2.3% | -7.1% | 3.4% |
| EPS (Basic) | 0.27 | 0.58 | 0.39 | (1.77) | 0.79 |
| EPS (Diluted) | 0.27 | 0.58 | 0.39 | (1.77) | 0.78 |
| Weighted Avg Shares | 60.84M | 60.84M | 60.84M | 62.01M | 62.39M |
| Weighted Avg Shares (Diluted) | 60.84M | 60.84M | 60.84M | 62.01M | 63.3M |
Guardian Pharmacy Services, Inc.
NYSE:GRDN
Intrinsic Alpha fair value
Locked
Current Price
$48.84
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.